Actively Recruiting

Phase Not Applicable
Age: 18Years - 24Years
All Genders
NCT05684094

Mechanisms of Risky Alcohol Use in Young Adults: Linking Sleep to Reward- and Stress-Related Brain Function

Led by University of Oregon · Updated on 2026-02-27

90

Participants Needed

1

Research Sites

181 weeks

Total Duration

On this page

Sponsors

U

University of Oregon

Lead Sponsor

U

University of Pittsburgh

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research will use biobehavioral approaches to generate understanding about the linkages between stressful life events, sleep duration and timing, and alcohol use in young adults, with a long-term aim of developing effective preventative interventions for alcohol use disorders.

CONDITIONS

Official Title

Mechanisms of Risky Alcohol Use in Young Adults: Linking Sleep to Reward- and Stress-Related Brain Function

Who Can Participate

Age: 18Years - 24Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 24 years
  • Past-month high-risk drinking defined as 4 drinks/day or 8/week for women, 5 drinks/day or 15/week for men
  • Short and late sleep (weekday sleep 7.5 hours and bedtime at or after midnight) or long and early sleep (weekday sleep over 7.5 hours and bedtime before midnight)
  • At least moderate lifetime exposure to stressors (2 or more events on the 20-item Adult Stress and Adversity Inventory-Screener)
  • Not currently in high school
  • Fluent in English
Not Eligible

You will not qualify if you...

  • Severe alcohol or substance use disorder (6 or more criteria in Diagnostic and Statistical Manual-5)
  • Acute alcohol intoxication on laboratory visit days (blood alcohol concentration of 0.02 or higher)
  • Current diagnosis of narcolepsy or idiopathic hypersomnia
  • Lifetime diagnosis of bipolar or schizophrenia spectrum disorder
  • Serious medical conditions such as neurological disorders, heart failure, or head injury with unconsciousness over 5 minutes
  • Conditions preventing MRI (e.g., ferrous metal in body)
  • Eye disease, epilepsy, or use of photosensitizing medications contraindicated with bright light therapy
  • Use of melatonin without willingness to stop during the study
  • Recent urgent suicide risk requiring immediate action
  • Recent travel across two or more time zones within one month prior to visits
  • Starting or stopping prescribed medication within 2 months before the study
  • Medication dose changes within five times the drug's half-life before study start
  • Anticipated medication changes during the study
  • Current symptoms of airborne infectious illness prior to lab visits
  • Positive breathalyzer screen (blood alcohol level > 0.02) on visit days, requiring rescheduling

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Oregon Sleep Lab

Eugene, Oregon, United States, 97403

Actively Recruiting

Loading map...

Research Team

A

Amanda Johnson

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here